GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (XSWX:MOVE) » Definitions » Return-on-Tangible-Equity

Medacta Group (XSWX:MOVE) Return-on-Tangible-Equity : 13.63% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Medacta Group Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Medacta Group's annualized net income for the quarter that ended in Dec. 2023 was CHF34.4 Mil. Medacta Group's average shareholder tangible equity for the quarter that ended in Dec. 2023 was CHF252.2 Mil. Therefore, Medacta Group's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was 13.63%.

The historical rank and industry rank for Medacta Group's Return-on-Tangible-Equity or its related term are showing as below:

XSWX:MOVE' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 18.45   Med: 34.16   Max: 75.45
Current: 18.85

During the past 9 years, Medacta Group's highest Return-on-Tangible-Equity was 75.45%. The lowest was 18.45%. And the median was 34.16%.

XSWX:MOVE's Return-on-Tangible-Equity is ranked better than
83.42% of 760 companies
in the Medical Devices & Instruments industry
Industry Median: 1.395 vs XSWX:MOVE: 18.85

Medacta Group Return-on-Tangible-Equity Historical Data

The historical data trend for Medacta Group's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group Return-on-Tangible-Equity Chart

Medacta Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only 18.48 38.17 34.95 22.65 18.45

Medacta Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.99 27.16 19.06 24.55 13.63

Competitive Comparison of Medacta Group's Return-on-Tangible-Equity

For the Medical Devices subindustry, Medacta Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medacta Group's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Medacta Group's Return-on-Tangible-Equity falls into.



Medacta Group Return-on-Tangible-Equity Calculation

Medacta Group's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=44.666/( (221.518+262.761 )/ 2 )
=44.666/242.1395
=18.45 %

Medacta Group's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=34.364/( (241.64+262.761)/ 2 )
=34.364/252.2005
=13.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Medacta Group  (XSWX:MOVE) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Medacta Group Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Medacta Group's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Medacta Group (XSWX:MOVE) Business Description

Traded in Other Exchanges
Address
Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopaedic and neurosurgical medical devices worldwide. The company offers solutions for Hip, Knee, Shoulder and Spine.